LEENO Industrial (A058470) Q4 2025 earnings summary

Executive summary

• Revenue for FY2025 reached KRW 372.5 billion, up 34% year-over-year, driven by strong growth in both semiconductor test equipment and medical device components.

• Operating income rose 43% to KRW 177.0 billion, with net income up 34% to KRW 152.0 billion, reflecting improved profitability and cost control.

• The company maintained a robust financial position with zero borrowings and a debt-to-equity ratio of 0%.

• Major investments included a new factory project in Busan Eco Delta City, with KRW 50.4 billion spent by year-end out of a planned KRW 97.2 billion.

Financial highlights

• Revenue: KRW 372.5 billion (+34% YoY); Operating income: KRW 177.0 billion (+43% YoY); Net income: KRW 152.0 billion (+34% YoY).

• Gross margin improved to 52.2% from 49.7% the previous year.

• Cash and cash equivalents at year-end: KRW 85.2 billion, up from KRW 54.8 billion.

• Dividend per share: KRW 800 (payout ratio 39.96%).

Outlook and guidance

• The company plans to maintain a dividend payout ratio around 40% and continue investing in capacity and R&D.

• Market demand for semiconductor and medical device components is expected to remain strong, supported by global trends in AI, IoT, and healthcare.